RAG-20

N/A

Report date: 2024/11/22 14:26:04
NME

Base Information

Drug NameRAG-20
Drug Alias NameRAG-20
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > small activating RNA
Mechanisms of ActionCoagulation factor VII stimulants
TargetsCoagulation factor VII
Therapy Area/IndicationsAcquired hemophiliaFactor VII Deficiency
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesRactigen Therapeutics (Nantong) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesRactigen Therapeutics (Nantong) Co Ltd
Inactive CompaniesN/A
Active IndicationsAcquired hemophiliaFactor VII Deficiency
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A